ARCH Venture Partners — 2024 Investments

Seaport Therapeutics develops therapeutics and medicines.

BiotechMental HealthBoston, US

Daphne Zohar(Founder, CEO and Board Member)Michael Chen(Executive Officer)Lana Gladstein(Executive Officer)Antony Loebel(Executive Officer)Eric Green(Executive Officer)

BoardJames I. Healy(Director)

Board seatRobert Nelsen· per SEC Form D

BiotechLexington, US

Steven Hyman(Director)James A. Geraghty(Director)Grace Colon(Director)Jude Onyia(Director)Robert W. Hesslein(Executive Officer)Todd Carter(Executive Officer)

Board seatGeorge Scangos· per SEC Form D · $20M raise · filed Jan 2024

Denali Therapeutics develops therapeutics for neurodegenerative diseases.

BiotechHealthtechMedical DevicesSan Francisco, US

Carole Ho(Executive Officer)Vicki L. Sato(Director)Nancy A. Thornberry(Director)Peter S. Klein(Director)Marc Tessier-Lavigne(Director)Jay T. Flatley(Director)

Autobahn develops medicines for central nervous system (CNS) disorders by leveraging regenerative mechanisms of the human body.

BiotechDeep TechMedical DevicesSan Diego, US

Kevin Finney(Chairman, President and CEO)John Borkholder(Executive Officer)

BoardThomas Cahill(Director)Timothy Anderson(Director)Philip J DeSouza(Director)

Board seatKristina Burow· per SEC Form D

BiotechBrookline, US

Luhan Yang(President, Secretary and Treasurer)Geoff MacKay(Chief Executive Officer)

BoardGeorge M. Church(Director)

Board seatSteven Gillis· per SEC Form D

Elephas develops elive, a live-tissue platform technology that predicts immunotherapy response in cancer patients by measuring real-time immune activity in intact tumor tissue.

BiotechDigital HealthHealthtechMedical DevicesMadison, US

Michelle B. Arora(Director)Terrence P. Brady(Executive Officer)Jonathan Oliner(Executive Officer)Maneesh K. Arora(Executive Officer, Director, Promoter)

Board seatPaul Berns· per SEC Form D

Pfizer is a pharmaceutical company that develops medicines for treating various diseases, with a focus on enriching and extending life through innovation in drug development and patient assistance programs.

HealthtechMedical Devices

Board seatKristina BurowPaul Berns· per SEC Form D

Mirador discovers and develops precision medicines for immune-mediated and immuno-fibrotic diseases using a target-patient matching approach.

AI & Machine LearningHealthtechMedical DevicesSan Diego, US

Joseph Papa(Director)Mark C. McKenna(Executive Officer, Director)Scott Glenn(Director)Vika Brough(Executive Officer)Timothy K. Andrews(Executive Officer)

Board seatKristina BurowPaul Berns· per SEC Form D

Rippl delivers evidence-based dementia care through a combination of technology and human support for people living with dementia and their families.

Digital HealthHealthtechSeattle, US

Kris Engskov(Co-founder & CEO)Robert Nelsen(Co-Founder & Board Chair)Paul Engskov(Executive Officer, Director)

BoardHolly Maloney(Director)Iyah Romm(Director)Ryan Watts(Director)

Board seatRobert Nelsen· per SEC Form D

BiotechNew Haven, US

Beatrice McQueen(Executive Officer)Aaron Ring(Manager)Jim Tananbaum(Manager)

Board seatSabah Oney· per SEC Form D · $10M raise · filed Feb 2024

Emeryville, US

Adam Wieschhaus(Director)Jeffrey Kim(Executive Officer, Director)Ronald J. Silberman(Director)

Board seatCorey RitterPatrick Weiss· per SEC Form D

Vizgen provides spatial multiomics platforms that enable researchers, clinicians, and biopharma teams to map and analyze RNA and protein molecules at single-cell resolution for disease understanding and precision medicine applications.

AI & Machine LearningBiotechMedical DevicesCambridge, US

Peng Yin(Director)Fenel Eloi(Director)Robert Carson(Executive Officer, Director)Peng Ying(Executive Officer, Director)David R. Walt(Executive Officer, Director)

BoardAndrea Jackson(Director)

Board seatKeith Crandell· per SEC Form D